Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|
Revenues | ||||
Services | $ 50,163 | $ 10,046 | $ 55,519 | $ 70,300 |
Product | 166,147 | 29,706 | 310,599 | 83,663 |
Total Revenues | 216,310 | 39,752 | 366,118 | 153,963 |
Operating Expenses | ||||
Research and development | 5,451,287 | 3,279,323 | 10,356,965 | 6,869,376 |
General and administrative | 2,644,957 | 3,085,840 | 5,226,660 | 5,687,992 |
Sales and marketing | 1,669,102 | 1,774,064 | 3,376,559 | 3,373,047 |
Total Operating Expenses | 9,765,346 | 8,139,227 | 18,960,184 | 15,930,415 |
Operating Loss | (9,549,036) | (8,099,475) | (18,594,066) | (15,776,452) |
Other Income (Expenses) | ||||
Grant income | 0 | 393,440 | 165,795 | 393,440 |
Interest income | 27,109 | 11,161 | 84,757 | 11,163 |
Interest expense | (58,321) | (37,129) | (109,643) | (78,161) |
Gain on change in fair value of warrant liability | 28,971 | 0 | 28,971 | 0 |
Total Other Income (Expenses) | (2,241) | 367,472 | 169,880 | 326,442 |
Net Loss | (9,551,277) | (7,732,003) | (18,424,186) | (15,450,010) |
Net Loss Attributable to Non-Controlling Interest | 80,298 | 82,302 | 173,659 | 166,279 |
Net Loss Attributable to VolitionRx Limited Stockholders | (9,470,979) | (7,649,701) | (18,250,527) | (15,283,731) |
Other Comprehensive Income (Loss) | ||||
Foreign currency translation adjustments | 37,712 | 214,097 | (18,766) | 96,193 |
Net Comprehensive Loss | $ (9,513,565) | $ (7,517,906) | $ (18,442,952) | $ (15,353,817) |
Net Loss Per Share - Basic and Diluted Attributable to VolitionRx Limited | $ (0.14) | $ (0.14) | $ (0.29) | $ (0.28) |
Weighted Average Shares Outstanding | ||||
- Basic and Diluted | 66,884,368 | 53,810,500 | 63,613,224 | 53,803,076 |
X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. No definition available.
|
X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|